“…Previous multicenter, multivendor head-to-head comparison trials have suggested that perfusion MRI is a valuable alternative to SPECT for the detection of significant anatomic CAD, with superior diagnostic performance, especially in multivessel disease (17)(18)(19). In a recent metaanalysis, myocardial perfusion MRI demonstrated a sensitivity of 89% and specificity of 87% for the diagnosis of hemodynamically significant CAD using a X-ray coronary angiography with fractional flow reserve as a reference standard on a per-patient level, which are similar to those of PET (84% and 87%, respectively) and superior to those of SPECT (74% and 79%, respectively) (20). In addition, vasodilator stress myocardial perfusion MRI provides prognostic value in patients with biomarker negative angina and reclassifies risk in patients with prior CAD (21,22).…”